Latest News & Features
Americas
Generics company Mylan Pharmaceuticals has resisted Allergan’s attempt to withdraw itself from a series of inter partes reviews (IPRs) relating to patents covering dry-eye medication Restasis (cyclosporine ophthalmic emulsion). 19 January 2018
Europe
Commentators have offered differing opinions on the impact of yesterday’s decision by the European Patent Office to revoke a CRISPR/Cas9 patent owned by the Broad Institute of Harvard and MIT. 18 January 2018
Americas
The Patent Trial and Appeal Board has invalidated a Johnson & Johnson patent covering its prostate cancer drug Zytiga (abiraterone acetate). 18 January 2018
Big Pharma
The UK Supreme Court has granted the UK BioIndustry Association permission to intervene in the case of Warner-Lambert Company v Generics and Actavis, which concerns the issue of ‘plausibility’. 18 January 2018
Europe
The Broad Institute of Harvard and MIT has said it will appeal against a decision by the European Patent Office to revoke one of its patents covering CRISPR/Cas9 technology. 17 January 2018
Big Pharma
Italian members of the European Parliament are fighting the European Medicines Agency’s relocation to the Netherlands. 16 January 2018
Europe
Today could play a pivotal role in the CRISPR patent landscape in Europe. 16 January 2018
Big Pharma
European IP boutique firm Hoyng Rokh Monegier has announced that Benoît Strowel will succeed Willem Hoyng as managing partner. 16 January 2018
Americas
Biopharmaceutical company MiMedx Group has settled a long-standing patent infringement dispute with the Musculoskeletal Transplant Foundation, Medline Industries and Liventa Bioscience. 15 January 2018
Americas
Healthcare firm Nuvo Pharmaceuticals has announced the acquisition of Resultz from US company Piedmont Pharmaceuticals. 15 January 2018